Pharmacotherapy of Binge-Eating Disorder: A Review

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of addiction medicine

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ADM.0000000000000089PMID 25629881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Binge Eating Disorder

  2014cited by this paper
• Pharmacological management of

  2014cited by this paper
• Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating.

  2013cited by this paper
• A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.

  2013cited by this paper
• The next generation of obesity treatments: beyond suppressing appetite

  2013cited by this paper
• Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.

  2013cited by this paper
• Theta brain rhythms index perceptual narrowing in infant speech perception

  2013cited by this paper
• Evidence-based pharmacotherapy of eating disorders.

  2012cited by this paper
• Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

  2012influential reference
• Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study

  2012cited by this paper
• Bupropion Versus Sertraline in the Treatment of Depressive Patients with Binge Eating Disorder: Retrospective Cohort Study

  2012cited by this paper
• Pharmacological management of binge eating disorder: current and emerging treatment options

  2012cited by this paper
• Neural correlates of food addiction.

  2011cited by this paper
• Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study.

  2011cited by this paper
• Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.

  2011cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders

  2011cited by this paper
• Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.

  2011cited by this paper
• Intra-accumbens baclofen, but not muscimol, mimics the effects of food withdrawal on feeding behaviour.

  2010cited by this paper
• Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.

  2010influential reference
• Combinations of Drugs in the Treatment of Obesity

  2010cited by this paper
• Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

  2010cited by this paper
• CRF system recruitment mediates dark side of compulsive eating

  2009cited by this paper
• Preliminary validation of the Yale Food Addiction Scale.

  2009cited by this paper
• Psychological treatments for bulimia nervosa and binging.

  2009cited by this paper
• Duloxetine in obese binge eater outpatients: preliminary results from a 12‐week open trial

  2009cited by this paper
• Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial

  2009influential reference
• Pharmacological targeting of the serotonergic system for the treatment of obesity

  2009cited by this paper
• Review and Meta‐analysis of Pharmacotherapy for Binge‐eating Disorder

  2008cited by this paper
• Memantine in the treatment of binge eating disorder: an open-label, prospective trial.

  2008cited by this paper
• Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.

  2008cited by this paper
• High‐dose escitalopram in the treatment of binge‐eating disorder with obesity: a placebo‐controlled monotherapy trial

  2008influential reference
• Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

  2007cited by this paper
• The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

  2007influential reference
• Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

  2007cited by this paper
• Sodium Oxybate

  2007cited by this paper
• Baclofen for binge eating: an open-label trial.

  2007influential reference
• A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters

  2006cited by this paper
• Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.

  2006influential reference
• Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study

  2005influential reference
• Treatment of Binge Eating Disorder with sertraline: A randomized controlled trial

  2005influential reference
• Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa

  2005cited by this paper
• Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan.

  2005cited by this paper
• Response of Recurrent Binge Eating and Weight Gain to Topiramate in Patients with Binge Eating Disorder after Bariatric Surgery

  2005cited by this paper
• An open trial of reboxetine in obese patients with binge eating disorder

  2005cited by this paper
• Effect of orlistat in obese patients with binge eating disorder.

  2005cited by this paper
• Pharmacological approaches in the treatment of binge eating disorder.

  2004cited by this paper
• Topiramate in the long-term treatment of binge-eating disorder associated with obesity.

  2004cited by this paper
• Medial prefrontal cortex activity associated with symptom provocation in eating disorders.

  2004cited by this paper
• Alcohol use disorder comorbidity in eating disorders: a multicenter study.

  2004cited by this paper
• Topiramate after Adjustable Gastric Banding in Patients with Binge Eating and Difficulty Losing Weight

  2004cited by this paper
• Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.

  2004cited by this paper
• Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat.

  2003cited by this paper
• A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response

  2003cited by this paper
• Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

  2003influential reference
• Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

  2003influential reference
• Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter.

  2003cited by this paper
• A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

  2003cited by this paper
• Repeated access to sucrose augments dopamine turnover in the nucleus accumbens

  2002cited by this paper
• Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.

  2002cited by this paper
• Opioid modulation of taste hedonics within the ventral striatum.

  2002cited by this paper
• A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

  2002cited by this paper
• Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.

  2002cited by this paper
• Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.

  2001cited by this paper
• Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain

  2001cited by this paper
• Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

  2000influential reference
• Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving.

  1998cited by this paper
• Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.

  1998influential reference
• Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect.

  1997cited by this paper
• d-fenfluramine treatment of binge eating disorder.

  1996cited by this paper
• A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder.

  1996cited by this paper
• Effect of naloxone on intake of cornstarch, sucrose, and polycose diets in restricted and nonrestricted rats.

  1996cited by this paper
• Selective effects of naltrexone on food pleasantness and intake.

  1996cited by this paper
• Co-morbidity of eating disorders and substance abuse review of the literature.

  1994cited by this paper
• Naloxone's anorectic effect is dependant upon the relative palatability of food

  1993cited by this paper
• Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing.

  1993cited by this paper
• Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist.

  1993cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement.

  1992cited by this paper
• Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes.

  1992cited by this paper
• Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects.

  1991cited by this paper
• A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus.

  1989cited by this paper
• Brain 3-hydroxybutyrate, glutamate, and GABA in a rat model of dietary obesity.

  1989cited by this paper
• Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

  1988cited by this paper
• The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone.

  1988cited by this paper
• Treatment of Antidepressant-Resistant Bulimia with Naltrexone

  1987cited by this paper
• Potentiation of reward by hunger is opioid mediated.

  1984cited by this paper
• Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat.

  1983cited by this paper
• Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol.

  1977cited by this paper

• GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases

  2025cites this paper
• An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.

  2022cites this paper
• Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice

  2022cites this paper
• Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder.

  2021cites this paper
• Corticostriatal dynamics underlying components of binge-like eating in mice

  2021cites this paper
• Emerging Translational Treatments to Target the Neural Networks of Binge Eating

  2020cites this paper
• A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder.

  2019cites this paper
• Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options.

  2019cites this paper
• Innovative Solutions for State Medicaid Programs to Leverage Their Data, Build Their Analytic Capacity, and Create Evidence-Based Policy

  2019cites this paper
• A Complex Case of Opiates and Related Pathologies

  2018cites this paper
• Repurposing Low Dose Lisdexamfetamine as Agonist Therapy for Stimulant Use Disorder: A Case Series

  2018cites this paper
• Becoming an Evidence-Based Practitioner

  2018cites this paper
• A Complex Case of Binge Eating Disorder (BED)

  2018cites this paper
• Eating Disorders: Anorexia Nervosa, Bulimia Nervosa, and Binge-Eating Disorders

  2017cites this paper
• Eating Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Anorexia Nervosa, Bulimia and Binge Eating Disorder

  2017cites this paper
• Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.

  2017cites this paper
• Binge-Eating Disorder in Adults

  2016cites this paper
• Eating Disorders and Obesity

  2016cites this paper
• Impulsivity and gambling: A complex clinical association across three measures.

  2016cites this paper